4//SEC Filing
Shukla Sanjay 4
Accession 0001209191-22-032204
CIK 0001339970other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:30 PM ET
Size
5.5 KB
Accession
0001209191-22-032204
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Shukla Sanjay
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2022-05-24+516,280→ 516,280 totalExercise: $2.81Exp: 2032-05-24→ Common Stock (516,280 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 24, 2022, such that this option will be fully exercisable on May 24, 2026. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001671026
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 4:30 PM ET
- Size
- 5.5 KB